Literature DB >> 10758967

Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.

C P Green1, C B Porter, D R Bresnahan, J A Spertus.   

Abstract

OBJECTIVES: To create a valid, sensitive, disease-specific health status measure for patients with congestive heart failure (CHF).
BACKGROUND: Quantifying health status is becoming increasingly important for CHF. The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire that quantifies physical limitations, symptoms, self-efficacy, social interference and quality of life.
METHODS: To establish the performance characteristics of the KCCQ, two distinct patient cohorts were recruited: 70 stable and 59 decompensated CHF patients with ejection fractions of <40. Upon entry into the study, patients were administered the KCCQ, the Minnesota Living with Heart Failure Questionnaire and the Short Form-36 (SF-36). Questionnaires were repeated three months later.
RESULTS: Convergent validity of each KCCQ domain was documented by comparison with available criterion standards (r = 0.46 to 0.74; p < 0.001 for all). Among those with stable CHF who remained stable by predefined criteria (n = 39), minimal changes in KCCQ domains were detected over three months of observation (mean change = 0.8 to 4.0 points, p = NS for all). In contrast, large changes in score were observed among patients whose decompensated CHF improved three months later (n = 39; mean change = 15.4 to 40.4 points, p < 0.01 for all). The sensitivity of the KCCQwas substantially greater than that of the Minnesota Living with Heart Failure and the SF-36 questionnaires.
CONCLUSIONS: The KCCQis a valid, reliable and responsive health status measure for patients with CHF and may serve as a clinically meaningful outcome in cardiovascular research, patient management and quality assessment.

Entities:  

Mesh:

Year:  2000        PMID: 10758967     DOI: 10.1016/s0735-1097(00)00531-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  476 in total

1.  Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement.

Authors:  Taku Inohara; Pratik Manandhar; Andrzej S Kosinski; Roland A Matsouaka; Shun Kohsaka; Robert J Mentz; Vinod H Thourani; John D Carroll; Ajay J Kirtane; Joseph E Bavaria; David J Cohen; Todd L Kiefer; Jeffrey G Gaca; Samir R Kapadia; Eric D Peterson; Sreekanth Vemulapalli
Journal:  JAMA       Date:  2018-12-04       Impact factor: 56.272

2.  Heart Failure Exercise And Training Camp: effects of a multicomponent exercise training intervention in patients with heart failure.

Authors:  Bunny Pozehl; Kathleen Duncan; Melody Hertzog; Joseph F Norman
Journal:  Heart Lung       Date:  2010-07-03       Impact factor: 2.210

3.  Predictors of objectively measured medication nonadherence in adults with heart failure.

Authors:  Barbara Riegel; Christopher S Lee; Sarah J Ratcliffe; Sabina De Geest; Sheryl Potashnik; Megan Patey; Steven L Sayers; Lee R Goldberg; William S Weintraub
Journal:  Circ Heart Fail       Date:  2012-05-30       Impact factor: 8.790

4.  Effect of an Early Palliative Care Telehealth Intervention vs Usual Care on Patients With Heart Failure: The ENABLE CHF-PC Randomized Clinical Trial.

Authors:  Marie A Bakitas; J Nicholas Dionne-Odom; Deborah B Ejem; Rachel Wells; Andres Azuero; Macy L Stockdill; Konda Keebler; Elizabeth Sockwell; Sheri Tims; Sally Engler; Karen Steinhauser; Elizabeth Kvale; Raegan W Durant; Rodney O Tucker; Kathryn L Burgio; Jose Tallaj; Keith M Swetz; Salpy V Pamboukian
Journal:  JAMA Intern Med       Date:  2020-09-01       Impact factor: 21.873

5.  Feasibility and acceptability of a collaborative care intervention to improve symptoms and quality of life in chronic heart failure: mixed methods pilot trial.

Authors:  David B Bekelman; Stephanie Hooker; Carolyn T Nowels; Deborah S Main; Paula Meek; Connor McBryde; Brack Hattler; Karl A Lorenz; Paul A Heidenreich
Journal:  J Palliat Med       Date:  2013-12-11       Impact factor: 2.947

6.  Does heart failure-specific health status identify patients with bothersome symptoms, depression, anxiety, and/or poorer spiritual well-being?

Authors:  Kelsey M Flint; Diane L Fairclough; John A Spertus; David B Bekelman
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2019-07-01

7.  Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial.

Authors:  Andrew P Ambrosy; Ankeet S Bhatt; Amanda L Stebbins; Lisa M Wruck; Marat Fudim; Stephen J Greene; William E Kraus; Christopher M O'Connor; Ileana L Piña; David J Whellan; Robert J Mentz
Journal:  Am Heart J       Date:  2018-02-11       Impact factor: 4.749

Review 8.  Strengthening the Learning Health System in Cardiovascular Disease Prevention: Time to Leverage Big Data and Digital Solutions.

Authors:  Anjali A Wagle; Nino Isakadze; Khurram Nasir; Seth Shay Martin
Journal:  Curr Atheroscler Rep       Date:  2021-03-10       Impact factor: 5.113

9.  Relationship Between Accelerometer-Measured Activity and Self-Reported or Performance-Based Function in Older Adults with Severe Aortic Stenosis.

Authors:  Yufei Tang; Philip Green; Mathew Maurer; Rosa Lazarte; Jonathan Rubin Kuzniecky; Ming Yang Hung; Melissa Garcia; Susheel Kodali; Tamara Harris
Journal:  Curr Geriatr Rep       Date:  2015-10-14

10.  Phosphodiesterase type 5 and high altitude pulmonary hypertension.

Authors:  A A Aldashev; B K Kojonazarov; T A Amatov; T M Sooronbaev; M M Mirrakhimov; N W Morrell; J Wharton; M R Wilkins
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.